InflaRx (IFRX) Net Income towards Common Stockholders (2016 - 2026)

InflaRx has disclosed Net Income towards Common Stockholders across 11 years of filings, most recently posting -$8.0 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$8.0 million, up 38.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $2148.2 billion (up 50646073.6% YoY), and the FY2025 annual result was -$53.1 million, down 7.91% from the prior year.
• Net Income towards Common Stockholders came in at -$8.0 million for Q1 2026 at InflaRx, down from $2148.2 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $2148.2 billion in Q4 2025 to a low of -$16.6 million in Q1 2022.
• The 5-year median for Net Income towards Common Stockholders is -$9.2 million (2023), against an average of $167.8 billion.
• Across the five-year window, Net Income towards Common Stockholders slumped 775.54% in 2023 and jumped 4652428.6% in 2025, its largest moves.
• InflaRx's Net Income towards Common Stockholders stood at -$7.8 million in 2022, then plunged by 83.11% to -$14.4 million in 2023, then jumped by 421.28% to $46.2 million in 2024, then surged by 4652428.6% to $2148.2 billion in 2025, then slumped by 100.0% to -$8.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$8.0 million (Q1 2026), $2148.2 billion (Q4 2025), and -$9.4 million (Q3 2025), per Business Quant data.